Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease

医学 传统PCI 经皮冠状动脉介入治疗 入射(几何) 左主干冠状动脉疾病 冠状动脉疾病 血运重建 心脏病学 累积发病率 内科学 比例危险模型 旁路移植 冠状动脉搭桥手术 动脉 心肌梗塞 队列 物理 光学
作者
Ioanna Kosmidou,Bahira Shahim,Ovidiu Dressler,Björn Redfors,Marie‐Claude Morice,John D. Puskas,David E. Kandzari,Dimitri Karmpaliotis,W. Morris Brown,Nicholas Lembo,Adrian Banning,A. Pieter Kappetein,Patrick W. Serruys,Joseph F. Sabik,Gregg W. Stone
出处
期刊:Journal of the American College of Cardiology [Elsevier BV]
卷期号:83 (11): 1073-1081 被引量:10
标识
DOI:10.1016/j.jacc.2024.01.012
摘要

The frequency of and relationship between hospital readmissions and outcomes after revascularization for left main coronary artery disease (LMCAD) are unknown. The purpose of this study was to study the incidence, predictors, and clinical impact of readmissions following percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) for LMCAD. In the EXCEL (XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial, 1,905 patients with LMCAD were randomized to PCI vs CABG. The cumulative incidence of readmissions was analyzed with multivariable Anderson-Gill and joint frailty models to account for recurrent events and the competing risk of death. The impact of readmission on subsequent mortality within 5-year follow-up was determined in a time-adjusted Cox proportional hazards model. Within 5 years, 1,868 readmissions occurred in 851 of 1,882 (45.2%) hospital survivors (2.2 ± 1.9 per patient with readmission[s], range 1-16), approximately one-half for cardiovascular causes and one-half for noncardiovascular causes (927 [49.6%] and 941 [50.4%], respectively). One or more readmissions occurred in 463 of 942 (48.6%) PCI patients vs 388 of 940 (41.8%) CABG patients (P = 0.003). After multivariable adjustment, PCI remained an independent predictor of readmission (adjusted HR: 1.22; 95% CI: 1.10-1.35; P < 0.0001), along with female sex, comorbidities, and the extent of CAD. Readmission was independently associated with subsequent all-cause death, with interaction testing indicating a higher risk after PCI than CABG (adjusted HR: 5.72; 95% CI: 3.42-9.55 vs adjusted HR: 2.72; 95% CI: 1.64-4.88, respectively; Pint = 0.03). In the EXCEL trial, readmissions during 5-year follow-up after revascularization for LMCAD were common and more frequent after PCI than CABG. Readmissions were associated with an increased risk of all-cause death, more so after PCI than with CABG.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zws完成签到,获得积分10
刚刚
无花果应助banban采纳,获得10
刚刚
隐形曼青应助aqione采纳,获得10
1秒前
量子星尘发布了新的文献求助10
2秒前
朝暮完成签到 ,获得积分10
4秒前
完美世界应助樊珩采纳,获得10
4秒前
5秒前
土书完成签到,获得积分10
6秒前
zz完成签到,获得积分10
7秒前
guibuzi完成签到,获得积分10
9秒前
罗小学完成签到,获得积分10
9秒前
gngxnh完成签到 ,获得积分10
9秒前
小张完成签到,获得积分10
9秒前
10秒前
当归发布了新的文献求助10
11秒前
12秒前
12秒前
阿明完成签到 ,获得积分10
13秒前
量子星尘发布了新的文献求助10
13秒前
13秒前
wjp完成签到 ,获得积分10
14秒前
111发布了新的文献求助10
14秒前
15秒前
乐观的大开关注了科研通微信公众号
16秒前
朴实的白玉完成签到,获得积分10
16秒前
冰山未闯完成签到,获得积分10
17秒前
杨海英发布了新的文献求助10
17秒前
刘显波完成签到,获得积分10
18秒前
yun发布了新的文献求助10
19秒前
YZYXR发布了新的文献求助10
19秒前
风趣霆发布了新的文献求助10
20秒前
852应助落寞酸奶采纳,获得10
21秒前
22秒前
22秒前
Akim应助zy采纳,获得10
23秒前
24秒前
英姑应助欢呼的冰蝶采纳,获得10
24秒前
赵世璧完成签到,获得积分10
25秒前
cgh123完成签到,获得积分20
25秒前
BOBO完成签到,获得积分10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Target genes for RNAi in pest control: A comprehensive overview 600
The Social Work Ethics Casebook(2nd,Frederic G. R) 600
HEAT TRANSFER EQUIPMENT DESIGN Advanced Study Institute Book 500
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 500
Master Curve-Auswertungen und Untersuchung des Größeneffekts für C(T)-Proben - aktuelle Erkenntnisse zur Untersuchung des Master Curve Konzepts für ferritisches Gusseisen mit Kugelgraphit bei dynamischer Beanspruchung (Projekt MCGUSS) 500
Design and Development of A CMOS Integrated Multimodal Sensor System with Carbon Nano-electrodes for Biosensor Applications 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5109272
求助须知:如何正确求助?哪些是违规求助? 4318042
关于积分的说明 13453386
捐赠科研通 4147922
什么是DOI,文献DOI怎么找? 2272930
邀请新用户注册赠送积分活动 1275085
关于科研通互助平台的介绍 1213282